AIMS/HYPOTHESIS: Long-term survival after myocardial infarction (MI) has improved in the population, but data on diabetic patients is lacking. We analysed survival for up to 18 years after a first MI in patients with or without diabetes. METHODS: The Northern Sweden MONICA Myocardial Infarction Registry was linked to the Cause-of-Death Registry for a total of 6,776 patients, 25-64 years of age, with a first MI during 1989-2006. Prehospital deaths were included. Follow-up ended on 30 August 2008. RESULTS: Sixteen per cent had diabetes. Median follow-up time was 6.8 years, and the study included 50,667 patient-years. One third of the non-diabetic patients died vs half of the diabetic patients. Median survival for non-diabetic men was 227 months and for diabetic men 123 months. Corresponding figures for the non-diabetic and diabetic women were 222 and 81 months respectively. Men with diabetes had an age-adjusted HR for all-cause mortality of 1.56 (95% CI 1.39, 1.79) vs men without diabetes. Mortality risk was higher among diabetic women, HR 1.97 (1.62, 2.39) (diabetes × sex interaction, p = 0.03). Survival increased for three consecutive cohorts and was higher in non-diabetic patients for all durations of follow-up and in all three cohorts. The interaction of diabetes x cohort was not significant over time (p = 0.5) and HRs did not differ either. CONCLUSIONS/ INTERPRETATION: Long-term survival after a first MI is markedly lower in diabetic patients, especially among women, over an 18-year observation time. Although survival has improved in diabetic patients, the effect of diabetes upon mortality has not diminished.
AIMS/HYPOTHESIS: Long-term survival after myocardial infarction (MI) has improved in the population, but data on diabeticpatients is lacking. We analysed survival for up to 18 years after a first MI in patients with or without diabetes. METHODS: The Northern Sweden MONICA Myocardial Infarction Registry was linked to the Cause-of-Death Registry for a total of 6,776 patients, 25-64 years of age, with a first MI during 1989-2006. Prehospital deaths were included. Follow-up ended on 30 August 2008. RESULTS: Sixteen per cent had diabetes. Median follow-up time was 6.8 years, and the study included 50,667 patient-years. One third of the non-diabeticpatients died vs half of the diabeticpatients. Median survival for non-diabeticmen was 227 months and for diabeticmen 123 months. Corresponding figures for the non-diabetic and diabeticwomen were 222 and 81 months respectively. Men with diabetes had an age-adjusted HR for all-cause mortality of 1.56 (95% CI 1.39, 1.79) vs men without diabetes. Mortality risk was higher among diabeticwomen, HR 1.97 (1.62, 2.39) (diabetes × sex interaction, p = 0.03). Survival increased for three consecutive cohorts and was higher in non-diabeticpatients for all durations of follow-up and in all three cohorts. The interaction of diabetes x cohort was not significant over time (p = 0.5) and HRs did not differ either. CONCLUSIONS/ INTERPRETATION: Long-term survival after a first MI is markedly lower in diabeticpatients, especially among women, over an 18-year observation time. Although survival has improved in diabeticpatients, the effect of diabetes upon mortality has not diminished.
Authors: Edward W Gregg; Qiuping Gu; Yiling J Cheng; K M Venkat Narayan; Catherine C Cowie Journal: Ann Intern Med Date: 2007-06-18 Impact factor: 25.391
Authors: Sarah Rosner Preis; Michael J Pencina; Shih-Jen Hwang; Ralph B D'Agostino; Peter J Savage; Daniel Levy; Caroline S Fox Journal: Circulation Date: 2009-07-06 Impact factor: 29.690
Authors: H L Koek; S S Soedamah-Muthu; J W P F Kardaun; E Gevers; A de Bruin; J B Reitsma; M L Bots; D E Grobbee Journal: Eur J Epidemiol Date: 2007-10-10 Impact factor: 8.082
Authors: Alexandra Kautzky-Willer; Raimund Weitgasser; Peter Fasching; Fritz Hoppichler; Monika Lechleitner Journal: Wien Klin Wochenschr Date: 2012-12 Impact factor: 1.704
Authors: Samuel S Engel; Gregory T Golm; Deborah Shapiro; Michael J Davies; Keith D Kaufman; Barry J Goldstein Journal: Cardiovasc Diabetol Date: 2013-01-03 Impact factor: 9.951